“…As shown in Tables 1 and 2 of 29 (6.9%) included metaanalyses, both published in specialty journals [34,43], reported receiving pharmaceutical industry funding, 11 (37.9%) reported non-industry funding [23, 26, 29-32, 35, 40, 49-51], 3 reported no study funding (10.3%) [28,33,46], and the funding source of 13 (44.8%) was not reported [24, 25, 27, 36-39, 41, 42, 44, 45, 47, 48]. Meta-analysis funding sources were reported for 8 of 11 meta-analyses from general medicine journals (72.7%) [23,26,[28][29][30][31][32][33], 5 of 15 (33.3%) from specialty medicine journals [34,35,40,43,46], and all 3 (100%) Cochrane reviews [49][50][51].…”